^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

LOP628

i
Other names: LOP628
News
Trials
Company:
Novartis
Drug class:
Microtubule inhibitor, c-KIT-targeted antibody-drug conjugate
Related drugs:
News
Trials